In addition, a PETA spokeswoman said Medtronic has pledged to extend animal welfare protections if animals are used in foreign contract laboratories.
In return, PETA has withdrawn a shareholder resolution calling on Medtronic to halt outsourcing animal experiments to China and other countries with inadequate animal-protection laws. Medtronic's annual meeting is Aug. 21.
"Typically what we do in these situations is formally address shareholders at companies' annual meetings and protest outside," said Holly Beal, a spokeswoman for Norfolk, Va.-based PETA.
However, Beal said Medtronic was willing to meet with the group twice yearly to discuss animal welfare issues and address the issue of foreign laboratories that test medical devices.
Medical technology companies often test experimental devices on animals before they are used on humans in clinical trials.
Medtronic spokeswoman Marybeth Thorsgaard declined to comment on the PETA agreement Tuesday.
However, rules guiding animal research are posted on the company's website, www.medtronic.com. The company said it will only use the smallest, most-reasonable number of animals in research, design studies to avoid unnecessary tests on animals, and explore alternatives to animal research.
Beal said PETA is especially concerned about U.S. companies that outsource animal testing to laboratories in China, where animal protection laws and regulations are lax.
Janet Moore --612-673-7752
To see more of the Star Tribune, or to subscribe to the newspaper, go to http://www.startribune.com/. Copyright (c) 2008, Star Tribune, Minneapolis Distributed by McClatchy-Tribune Information Services. For reprints, email tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index